# FDA Inspection 1265132 - Renate Strehlau, PhD - March 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/renate-strehlau-phd/9a2bb24a-e5be-41ea-b14a-2dcd16db8f19
Source feed: FDA_Inspections

> FDA Inspection 1265132 for Renate Strehlau, PhD on March 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265132
- Company Name: Renate Strehlau, PhD
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265132 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/renate-strehlau-phd/ebecc920-4cee-4b8d-931e-d355b4fde28b)

Company: https://www.keypedia.com/companies/renate-strehlau-phd/2adb32b1-5634-4aa4-a684-e944fd464f53

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c